Enhancement of Vaccinia Virus Based Oncolysis with Histone Deacetylase Inhibitors

A High-throughput Pharmacoviral Approach Identifies Novel Oncolytic Virus Sensitizers

(2010) Jean-Simon Diallo et al.   MOLECULAR THERAPY

Histone deacetylase inhibitors as anti-neoplastic agents

(2009) Nicolas Batty et al.   CANCER LETTERS

Engineering oncolytic viruses to exploit tumor specific defects in innate immune signaling pathways

(2009) Shruthi Naik et al.   EXPERT OPINION ON BIOLOGICAL THERAPY

Vaccinia Virus K1L and C7L Inhibit Antiviral Activities Induced by Type I Interferons

(2009) X. Meng et al.   JOURNAL OF VIROLOGY

Effect of anti-fibrinolytic therapy on experimental melanoma metastasis

(2008) Jennifer M. Kirstein et al.   CLINICAL & EXPERIMENTAL METASTASIS

Use of a targeted oncolytic poxvirus, JX-594, in patients with refractory primary or metastatic liver cancer: a phase I trial

(2008) Byeong-Ho Park et al.   LANCET ONCOLOGY

Histone Deacetylase Inhibitors Augment Antitumor Efficacy of Herpes-based Oncolytic Viruses

(2008) Akihiro Otsuki et al.   MOLECULAR THERAPY

The Targeted Oncolytic Poxvirus JX-594 Demonstrates Antitumoral, Antivascular, and Anti-HBV Activities in Patients With Hepatocellular Carcinoma

(2008) Ta-Chiang Liu et al.   MOLECULAR THERAPY

Chemical targeting of the innate antiviral response by histone deacetylase inhibitors renders refractory cancers sensitive to viral oncolysis

(2008) T. L.-A. Nguyen et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Antagonizing activity of vaccinia virus E3L against human interferons in Huh7 cells

(2008) Janilyn Arsenio et al.   VIROLOGY

Myxoma Virus Oncolysis of Primary and Metastatic B16F10 Mouse Tumors In Vivo

(2007) Marianne M Stanford et al.   MOLECULAR THERAPY